Decreased expression of hepatocyte nuclear factor 3 alpha during the acute-phase response influences transthyretin gene transcription.
about
Hepatocyte nuclear factor 3/fork head homolog 11 is expressed in proliferating epithelial and mesenchymal cells of embryonic and adult tissuesFoxA proteins regulate H19 endoderm enhancer E1 and exhibit developmental changes in enhancer binding in vivoDifferential expression of forkhead box transcription factors following butylated hydroxytoluene lung injury.The systemic amyloid precursor transthyretin (TTR) behaves as a neuronal stress protein regulated by HSF1 in SH-SY5Y human neuroblastoma cells and APP23 Alzheimer's disease model mice.Liver-specific alpha 2 interferon gene expression results in protection from induced hepatitis.Support for the multigenic hypothesis of amyloidosis: the binding stoichiometry of retinol-binding protein, vitamin A, and thyroid hormone influences transthyretin amyloidogenicity in vitro.Premature expression of the winged helix transcription factor HFH-11B in regenerating mouse liver accelerates hepatocyte entry into S phase.Elevated levels of hepatocyte nuclear factor 3beta in mouse hepatocytes influence expression of genes involved in bile acid and glucose homeostasis.Progenitor-derived hepatocellular carcinoma model in the rat.The winged helix transcriptional activator HFH-3 is expressed in the distal tubules of embryonic and adult mouse kidney.Genetic variation of the transthyretin gene in wild-type transthyretin amyloidosis (ATTRwt).FOXA1 in breast cancer.Coexistence of C/EBP alpha, beta, growth-induced proteins and DNA synthesis in hepatocytes during liver regeneration. Implications for maintenance of the differentiated state during liver growth.Rho GTPases in endoderm development and differentiation.The inflammation-induced down-regulation of plasma Fetuin-A (alpha2HS-Glycoprotein) in liver results from the loss of interaction between long C/EBP isoforms at two neighbouring binding sitesModulation of hepatocyte nuclear factor-4alpha function by the peroxisome-proliferator-activated receptor-gamma co-activator-1alpha in the acute-phase response.The transcriptional activator hepatocyte nuclear factor 6 regulates liver gene expression.Expression of hepatocyte nuclear factor 6 in rat liver is sex-dependent and regulated by growth hormone.Global analysis of in vivo Foxa2-binding sites in mouse adult liver using massively parallel sequencingAnimal models of human amyloidoses: are transgenic mice worth the time and trouble?MicroRNA-212 targets FOXA1 and suppresses the proliferation and invasion of intrahepatic cholangiocarcinoma cells.Two mutations in the promoter region of the human protein C gene both cause type I protein C deficiency by disruption of two HNF-3 binding sites.Expression of hepatocyte nuclear factor-3alpha in rat prostate, seminal vesicle, and bladder.Rapid hepatocyte nuclear translocation of the Forkhead Box M1B (FoxM1B) transcription factor caused a transient increase in size of regenerating transgenic hepatocytes.The diversity of mechanisms influenced by transthyretin in neurobiology: development, disease and endocrine disruption.Regulation of hepatocyte identity and quiescence.E1A represses apolipoprotein AI enhancer activity in liver cells through a pRb- and CBP-independent pathway.Endotoxin, zymosan, and cytokines decrease the expression of the transcription factor, carbohydrate response element binding protein, and its target genes.Endotoxin-induced renal inflammatory response. Oncostatin M as a major mediator of suppressed renin expression.Distal renal tubular acidosis in mice that lack the forkhead transcription factor Foxi1Activation of CAAT enhancer-binding protein delta (C/EBPdelta) by interleukin-1 negatively influences apolipoprotein C-III expression.Effect of dietary protein restriction on liver transcription factors.Chronic lithium administration down regulates transthyretin mRNA expression in rat choroid plexus.The mouse alpha-fetoprotein promoter is repressed in HepG2 hepatoma cells by hepatocyte nuclear factor-3 (FOXA).Hepatocyte nuclear factor 4 response to injury involves a rapid decrease in DNA binding and transactivation via a JAK2 signal transduction pathway.Distinct gene expression programs function in progenitor and mature islet cells.In vivo and in vitro regulation of sterol 27-hydroxylase in the liver during the acute phase response. potential role of hepatocyte nuclear factor-1.Extracellular ATP activates c-jun N-terminal kinase signaling and cell cycle progression in hepatocytes.Interleukin-12 inhibits liver-specific drug-inducible systems in vivo.MicroRNA regulation of Transthyretin in trophoblast differentiation and Intra-Uterine Growth Restriction.
P2860
Q24319881-EF529B89-8F2C-41EF-ABDA-A7197B6C6D89Q28505087-037F390D-D243-4BF9-8A35-4168E32FCA0EQ32128097-E0565DFB-B76F-45B2-B0D1-E94AA8B3FF3BQ33639507-94F2229B-505F-4963-B32D-5AAF380BEBE0Q33804926-486AD139-9C1C-4648-B67C-23123A8E58BBQ33949040-43DE3294-C8B6-4F5A-B697-8BC8C4B93A0EQ33960953-C6BE75F9-E560-40DC-9969-A4274FF4CE32Q33966276-C7FA5F26-A6AF-4BE3-A7F5-48B669C6C1DCQ34037698-F0C754E4-42B0-4AEF-AA37-E1EE08F5EFF2Q34426374-6B030B98-A92E-491D-BCA4-421C1D5F8B79Q34810495-B4560176-703E-474F-82F8-7ED26C6DF5A8Q34956469-FC532572-EAD7-49F3-A356-5689365AA700Q35762870-3503E3F7-3860-4F9F-9516-F5217421292CQ36100854-59A911EF-811A-4526-9766-451E9097336AQ36372808-F12F8E08-71B9-461F-BDF7-91DE2676095DQ36555166-A91CEA08-E263-4FC4-BEF2-CE9BD4977114Q36563623-068CA968-9C9B-4015-8DF3-FE1F11321A5BQ36801225-F1F77D22-A578-42F8-B6C3-24F9679754B4Q36824035-ACF453F6-A625-4326-8F01-554B0FEB9810Q37560167-B4713B91-1350-4E16-9022-1F623ACC60D6Q37582141-C5E95B53-F569-4920-9F74-87B8B05B6280Q38290368-6B0032E2-269B-4021-933D-DA0F5FBD11ABQ38339613-41F98EB4-D4D7-4C24-BFE4-D23DD51ECB21Q38346703-F4DE4C1C-3619-4615-B19A-5D062ADB59B9Q38367420-1F6144E6-CAE5-4554-BB2F-4BF7963E0404Q38531851-A1518746-FE4F-4D83-BBE0-0C58C049BCF9Q39723402-58674098-295C-4D53-8ED9-78F6DAD6AA49Q39748093-46F8AC39-6139-47FE-8E5E-7BB82ADCE24EQ40880558-08F242DB-C575-4741-B269-3A98EDC71351Q40900005-0796B7DF-2CE4-4B25-AFDA-91B8C0BC5C6DQ41091114-9FDDF33C-60EA-47E9-B386-636A94D98283Q41834910-01C49114-4256-43A6-BE0B-F473D3244A5FQ41850781-E20C694C-E54D-485E-BF07-96D7F9C732C0Q41862835-830FD0AE-AF2F-4EFD-B097-5C59CE06445BQ42031765-5D9D83E0-24F8-4D8F-9CD0-F19CE5B109FFQ42804796-F79CADB8-5D91-4A7C-91E8-407771A74C35Q43640406-82E6F201-EEB5-4FFF-B559-CC852B787970Q44759282-1DBE3AC4-AC1C-43E0-841D-27D6E26ECEA0Q45873059-20FB7FB6-EAFD-48AC-B5C1-A6FF3F053CF4Q47108034-E4193BCA-8A05-49B9-80A9-C67AE53732BA
P2860
Decreased expression of hepatocyte nuclear factor 3 alpha during the acute-phase response influences transthyretin gene transcription.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Decreased expression of hepato ...... nsthyretin gene transcription.
@ast
Decreased expression of hepato ...... nsthyretin gene transcription.
@en
type
label
Decreased expression of hepato ...... nsthyretin gene transcription.
@ast
Decreased expression of hepato ...... nsthyretin gene transcription.
@en
prefLabel
Decreased expression of hepato ...... nsthyretin gene transcription.
@ast
Decreased expression of hepato ...... nsthyretin gene transcription.
@en
P2093
P2860
P356
P1476
Decreased expression of hepato ...... nsthyretin gene transcription.
@en
P2093
P2860
P304
P356
10.1128/MCB.15.3.1364
P407
P577
1995-03-01T00:00:00Z